Special Issue | DaBomb Protein Biotech Pioneers and Advances a New Era of Animal-Specific Postbiotics

Partnering with National Chung Hsing University on a Technology Transfer Agreement to Comprehensively Drive Green, Antibiotic-Free Farming Technology

COMPILED BY CHIANG YI-HSUAN

Global livestock and aquaculture industries are rapidly moving away from reliance on antibiotics, with "green antibiotic reduction" and environmental sustainability emerging as shared challenges of the era for the animal nutrition fermentation industry. As a pioneer in this field, DaBomb Protein Biotech Co., Ltd. (stock code: 6578) formally signed a technology transfer agreement with National Chung Hsing University (NCHU) this past July, writing a new chapter in the company's antibiotic-replacement technology portfolio and setting a fresh milestone for the global animal-specific postbiotics industry.

At the signing ceremony, DaBomb Protein Biotech Chairman Chen Wei-Chen personally signed the agreement together with Professor Lee Tzai-Tai of NCHU's Department of Animal Science and the university's Industry-Academia-Research Liaison Center, announcing the exclusive licensing of a probiotic application technology recognized with the 22nd National Innovation Award and protected by multiple patents. This marks not only a new starting point in DaBomb Protein's history of industry-academia collaboration, but also the company's formal entry into an era-defining new chapter in the fields of antibiotic-free feed additives, green farming, and precision nutrition.

"Safeguarding animal health and environmental sustainability is DaBomb Protein's unwavering mission. The addition of National Chung Hsing University's research achievements not only strengthens our competitive moat in antibiotic-replacement technology, but also creates a perfect synergy with our existing DBT-100 series (probiotics and postbiotics) products. With this green technology capability, we will comprehensively help our customers reduce costs and improve efficiency as we move toward a new era of global antibiotic-free farming."

— DaBomb Protein Biotech Chairman Chen Wei-Chen

Technology Achievements and Industry Applications

1. Mature Microbial Ecology Fermentation Technology

DaBomb Protein Biotech possesses deep, well-established core fermentation technology in microbial ecology and has long been committed to the R&D and production of fermented plant protein products. This technology transfer will be deeply integrated with the company's two existing flagship product lines: DBT-100 LS (the livestock series), which targets the economic animal market, and DBT-100 HT (the aquaculture series), the rising star that recently drew strong attention at World Aquaculture 2026, Singapore. The high heat stability of the transferred technology allows the products to fully withstand the demanding high-temperature pelleting conditions of feed processing, ensuring that probiotic activity effectively reaches the animal gut and delivers its intended function.

2. Integration with Flagship Product Technology

By combining this R&D achievement with functional prebiotics, postbiotics, and high-quality fermented plant proteins, DaBomb Protein Biotech is comprehensively helping leading feed manufacturers at home and abroad implement "high-efficiency, antibiotic-free" rearing standards. This represents not merely a technological upgrade, but a paradigm shift for the industry—from traditional antibiotic-dependent farming toward a green, sustainable model centered on precision nutrition and microbial ecology technology.

3. Strategic Positioning in Functional Postbiotics

Standing at this new starting point, DaBomb Protein Biotech will continue to deepen its foundation of academic collaboration, translating laboratory innovations into practical, industry-ready solutions, and leading the global animal health industry toward a new era defined by antibiotic-free, green, and sustainable practices.